Open Access Open Access  Restricted Access Access granted  Restricted Access Subscription or Fee Access

Vol 13, No 3 (2021)

Articles

Prevalence of chronic kidney disease in primary care patients. results of a prospective observational study in 12 regions of Russia

Essaian A.M., Arutyunov G.P., Melikhov O.G.

Abstract

Background. Chronic kidney disease (CKD) has become a pandemic in recent decades, being the fifth most common cause of death from noncommunicable diseases. CKD is a risk factor for the development of cardiovascular diseases and associated mortality, and the treatment of these diseases requires significant health care costs. Early diagnosis and promptly prescribed diet and treatment for CKD can prevent or slow the progression of the disease.Objective. Determination of the proportion of primary care patients with risk factors, signs and symptoms of CKD who are not be followed up by a nephrologist.Material and methods. A prospective non-interventional observational study "Early diagnosis of chronic kidney disease in primary health care facilities" ("CKD screening") in routine clinical practice was carried out in 12 regions of the Russian Federation. All patients who met the inclusion criteria and had at least one sign, symptom or risk factor for CKD who visited participating primary health care (PHC) physicians during the project period were screened for the purposes of this study. Primary care physicians assessed risk factors, signs and symptoms of possible CKD using a questionnaire developed by the study authors. Patients with suspected CKD were advised to see a nephrologist. Descriptive statistics methods were used. No comparative analysis has been carried out. Continuous variables are represented by the number of observations, mean (Mean) with standard deviation (SD) and standard error (SE), first (Q1), second (Median) and third (Q3) quartiles, range of values (Min; Max).Results. 13,968 patients visited the PHC physicians participating in the project; 1124 (8%) of them were referred to a nephrologist by the PHC physician. The diagnosis of CKD was confirmed in 95% of patients further examined by a nephrologist. Distribution by CKD stages: C1 - 2.4%, C2 - 11.6%, C3 - 71.9%, C4 - 10.8% and C5 - 2.9%. Among patients with CKD C3: 33.4% had CKD C3a and 30.7% had CKD C3b. Among patients with confirmed CKD: 59% had uncontrolled arterial hypertension (AH), 50% were over 65 years old, chronic heart failure was present in 44% of patients, diabetes - in 34%, abdominal obesity - in 32%. Other diseases were less important as a risk factor for the development of CKD. The low-protein diet was prescribed by the nephrologists in 84.6% of patients.Conclusion. The prevalence of CKD in the Russian Federation is similar to the global rates. Among patients with CKD, stage C3 disease with high risk of progression to end-stage CKD, as well as the risk of cardiovascular mortality and morbidity prevails. The study reaffirmed that uncontrolled hypertension, age over 65, chronic heart failure, diabetes and abdominal obesity are the most important risk factors for CKD, and patients with these conditions or diseases need mandatory CKD screening. The scoring system for assessing the risks of CKD proposed by the authors, along with the traditional assessment of glomerular filtration rate and albuminuria, seems to be a suitable tool for early detection of renal dysfunction; further research to study the specificity and sensitivity of the proposed method is planned.
Clinical nephrology. 2021;13(3):6-16
pages 6-16 views

Kidney damage in the newcoronavirus disease COVID-19

Gromova G.G., Verizhnikova L.N., Zhbanova N.V., Stepovaya A.V., Tyurina I.A.

Abstract

Objective. Analysis of the kidney damage in COVID-19 patients in Surgut. Material and methods. A retrospective cohort clinical study of kidney damage in a new coronavirus infection was carried out; study included 136 patients treated at the Surgut Regional Clinical Hospital from 24.06.2020 to 24.07.2020.Results and conclusion. Changes in urinanalysis were registered in 70.9% of patients: proteinuria without edema and hypoalbuminemia - in 76.8% (73 patients). A transient increase in creatinine levels without the development of acute kidney injury (AKI) was detected in 16.4% (22 patients) of patients with coronaviral disease. AKI was diagnosed in 17.6% (24) patients. The mean glomerular filtration rate according to the CKD-EPI formula in the AKI group was 46.9 ml/min. In patients with a new coronavirus infection no associations of the incidence of AKI with gender, age, severity of coronavirus infection and a certain class of comorbidity were found. Negative dynamics according to computed tomography data in AKI patients was observed in 54% of cases. In 91.8%, the results of calculating concentration indices made it possible to regard AKI as prerenal
Clinical nephrology. 2021;13(3):17-22
pages 17-22 views

Risk factors for development of severe hypocalciemia after paratyreoidectomy for secondary hyperparathyroidisis in dialysis patients

Kislyy P.N., Parshina E.V., Zulkarnaev A.B., Tolkach A.D., Mikhailova S.S., Chernikov R.A., Zarya Y.V.

Abstract

Objective. determination of thethe risk factors for severe hypocalcemia after parathyroidectomy (PTE) for secondary hyperparathyroidism (SHPT) in dialysis-dependent patients. material and methods. The retrospective study included 640 patients who underwent successful pte for shpt. severe hypocalcemia was defined as a blood ionized calcium level of less than o.9 mmol/l on days 2-3 after surgery. results. severe hypocalcemia during the second or third day of the postoperative period was detected in 76.7% of patients. The following factors were associated with the risk of its development: young age (P
Clinical nephrology. 2021;13(3):23-30
pages 23-30 views

Peculiarities of vascular remodeling in patients with chronic kidney disease stage 5D: prognostic role of the intima-media thickness

Kolomyitseva M.N., Gasanov M.Z., Batyushin M.M., Manukyan O.M., Rudenko L.I.

Abstract

Objective. to assess the factors influence the intima-media thickness (IMT) in patients with ckd stage sd, as a key marker of vascular remodeling, reflecting the severity of endothelial dysfunction. material and methods. the study included 40 patients (22 men and 18 women) with chronic kidney disease receiving hemodialysis (HD) treatment. the average age of the patients was S8.9±13.i years. the mean duration of the disease leading to end-stage renal disease (ESRD) was 10.9±i.s years, the mean duration of renal replacement therapy (RRT) was S3.6±7.s months. In all patients, clinical and anamnestic data were assessed, laboratory studies, bioimpedansometry were performed, ultrasound examination of the carotid arteries was performed, and the imt was determined. statistical analysis was performed using statistica io.o software. results. it was found that with age in patients with ckd sd, the imt of the common carotid artery (CCA) increased (r=0.5S; p<0.05). the duration of renal dysfunction was associated with an increase in cca imt (r=0.19; p<0.0S). an increase in the cca imt was found in hypoalbuminemia, hyperglycemia, as well as an increase in the level of il-6. the survival rate of patients in the group 2 years after the start of follow-up was 80%. when assessing the cca imt, it was found that among the deceased, this indicator was significantly higher than in the group of survivors and amounted to 1.02±0.11 mm versus 0.8±0.4 mm, respectively (P<0.05). Conclusion. thus, an increase in il-6 levels, duration of ckd, electrolyte imbalance, hypoalbuminemia, hyperglycemia, and an increase in renal arterial vascular resistance were accompanied by an increase in the likelihood of an increase in cca imt. increased in cca imt has also been associated with a poor prognosis.
Clinical nephrology. 2021;13(3):31-37
pages 31-37 views

Indicators of endogenous intoxication and lipid peroxidation in the dynamics of treatment with α-lipoic acid in men with diabetic nephropathy at the stage of microalbuminuria

Darenskaya M.A., Chugunova E.V., Kolesnikov S.I., Grebenkina L.A., Semenova N.V., Nikitina O.A., Kolesnikova L.I.

Abstract

Background. Elucidation of the mechanisms contributing to the development of the initial stages of diabetic nephropathy and their timely correction are extremely topical issues for specialists. objective. assessment of the indices of endogenous intoxication and lipid peroxidation products in men with type l diabetes MELLITUS (DMl) with microalbuminuria in the dynamics of treatment with a-LIPOIC acid. material and methods. the study was carried out with the participation of 28 men of reproductive age with dmi and microalbuminuria in the dynamics of treatment with a-LiPOic acid. The control group consisted of 28 healthy men. The comparison group consisted of 18 men of the same age with dmi and normoalbuminuria. the content of medium molecular weight peptides (MMWP), absorbing at 238, 254, 280 nm, as well as the concentration of primary, secondary and end products of lipid peroxidation were estimated. spectrophotometry and fluorometry methods were used. results. the results of the examination of men with dmi and microalbuminuria compared to the control showed an increase in the levels of mmwp-238, -280, as well as lipid peroxidation products - diene conjugates (DC), ketodienes and conjugated trienes, tba-reactive substances (TBARS) and schiff bases (SB); compared to the comparison group - increased values of mmwp-280, tbars and sb. after the treatment with a-LiPoic acid, there was a decrease in the levels of mmwp-280, dc, tbars and sb. Conclusion. the data obtained demonstrate the presence of metabolic manifestations of endogenous intoxication and activation of lipid peroxidation processes at different stages in patients with DM1 and microalbuminuria. The treatment with a-LIPOIC acid contributed to the relative normalization of these parameters. the need to control and correct these indicators in male patients with dmi and early manifestations of diabetic nephropathy should be an important component of pathogenetic treatment and prevention of complications.
Clinical nephrology. 2021;13(3):38-43
pages 38-43 views

A patient with systemic lupus erythematosus and lupus nephritis: the potentials for biological therapy

Damyanov N., Vinogradova I.B., Bezgin A.V., Knyazeva L.A.

Abstract

Objective. evaluation of the clinical and laboratory dynamics of patients with systemic lupus erythematosus (SLE) and lupus nephritis (LN) during therapy with belimumab. material and methods. the study included 18 patients with sle and lupus kidney disease who received belimumab in addition to standard therapy. Evaluation of immunological parameters (anti-native double-stranded DNA antibody titers, сз, C4 complement component levels), biochemical parameters (cholesterol, creatinine, total blood protein levels), changes in clinical urinalysis (proteinuria, cylindruria, leukocyturia, erythrocyturia) was performed; dynamics of glomerular filtration rate (GFR), daily proteinuria and the selena-sledai index, obtained in different periods from the start of treatment with belimumab (о, 2, 6 and 12 months) were analyzed. results. The positive dynamics of clinical and laboratory symptoms (a decrease in the main disease symptoms, a positive dynamics of laboratory parameters and an improvement in the general condition) of patients were revealed. Conclusion. The use of belimumab at a dose of 10 mg/kg in addition to standard therapy for patients with sle and LN reduces the clinical and immunological activity of sle, decreases the level of daily proteinuria, decreases the creatinine level, and allows deescalating the dose of glucocorticosteroids taken.
Clinical nephrology. 2021;13(3):44-48
pages 44-48 views

Homocystein and folic acid in chronic kidney disease: clinical and predictive significance

Murkamilov I.T., Aitbaev K.A., Fomin V.V., Murkamilova Z.A., Yusupov F.A., Kudaibergenova I.O.

Abstract

Objective. Evaluation of the relationship between homocysteine (HC) and folic acid (FA) concentration with the presence and severity of renal failure in patients with chronic kidney disease (CKD). Material and methods. A cross-sectional study with the inclusion of 388 people aged 18 to 89 years was carried out. The main group consisted of 216 patients with an established diagnosis of CKD. The control group included 172 patients who had no signs of CKD according to the results of clinical and laboratory examination. Serum HC, FA, total cholesterol, sodium, calcium and creatinine level were analyzed in all study participants. Kidney function was assessed by glomerular filtration rate (GFR) using the CKD-EPI formula. Results. There were no significant differences in age, anthropometric and hemodynamic parameters between the patients of the studied groups. In the group of patients with CKD, the incidence of arterial hypertension (63.8%), type 2 diabetes mellitus (31.0%), coronary artery disease (29.1%), chronic cerebral ischemia (10.1%) and comorbid pathology (42.1%) were significantly higher, and the serum calcium level was significantly lower (2.105±0.348 versus 2.313±0.360 mmol/L; P<0.05) compared with the group without CKD. Among all study participants (n=388), hyperhomocysteinemia was detected in 196 (50.5%) patients. The serum homocysteine (HC) level was significantly higher in patients with CKD. The frequency of hyperhomocysteinemia among the examined patients with CKD was 175 (81.0%), in the control group - 21 (12.2%). Hyperhomocysteinemia was most often detected among male patients with CKD - 58 (58.5%). As the renal function decreased, the blood serum HC level increased significantly. Among the examined individuals, FA deficiency was detected in 108 (27.8%) patients. A decrease in the FA level below the optimal value was found in 67 (31.0%) patients with CKD, and in the control group - in 41 (23.8%) (P>0.05). In patients with CKD, significantly low FA levels were recorded at the C3A stage of the disease. A positive strong correlation between HC and creatinine levels (r=0.6267; P<0.005) and a negative correlation with GFR (r=-0.5963; P<0.05) and serum calcium level (r=-0.2094; P<0.05) were demonstrated. Conclusion. In patients with CKD, significantly high serum HC level was observed. With a decrease in renal function, the blood serum HC level increased significantly. Hyperhomocysteinemia was found significantly more frequently among male patients with CKD. A decrease in the FA level was observed among patients with CKD at the C3A stage of the disease. In CKD, the serum HC level not only determines the severity of renal failure and the risk of cardiovascular complications, but, possibly, is a marker of mineral bone disorders. In this regard, the determination of the blood serum HC and FA levels is of certain scientific and practical interest
Clinical nephrology. 2021;13(3):49-56
pages 49-56 views

On the issue of morphological changes in the kidneys when using nasvay

Ayypova D.A., Mukanbaeva A.K., Beishebaeva N.A., Kaliev R.R.

Abstract

The article presents a clinical observation and a review of the literature on kidney damage with long-term use of smokeless tobacco (nasvay). nasvay is a type of smokeless tobacco containing over 2000 chemical compounds classified as strong carcinogens. The production of nasvay in the central Asian countries is not controlled, and the composition is not regulated. on the example of a clinical case, the rapid course of nephrotic syndrome, specific kidney damage according to biopsy data and a poor prognosis are demonstrated.
Clinical nephrology. 2021;13(3):57-60
pages 57-60 views

Thrombocytosis as a cause of thrombohemorrhagic complications in the practice of a nephrologiste

Mikhailova Z.D., Cherepanova V.V.

Abstract

Thrombocytosis - an increase in the number of platelets over 450xio9/l. Clinical case. a clinical case of a patient with thrombocytosis and end-stage renal failure associated with urolithiasis, ischemic heart disease and arterial hypertension, diabetes mellitus, treated with hemodialysis, insulin, erythropoietin is presented. differential diagnosis for thrombocytosis presents difficulties for doctors of various specialties. complications of thrombocytosis are little known to a wide range of practicing doctors.
Clinical nephrology. 2021;13(3):61-65
pages 61-65 views

Membranose glomerulonephritis in the practice of a therapist

Murkamilov I.T., Sabirov I.S., Fomin V.V., Murkamilova Z.A., Kudaibergenova I.O., Yusupov F.A.

Abstract

Membranous glomerulonephritis (MGN) is characterized by diffuse thickening and changes in the structure of the basement membrane of the glomeruli due to subepithelial and intramembranous deposition of immune complexes and the deposition of matrix material produced by affected podocytes. As the most common cause of nephrotic syndrome in adults, MGN is divided into primary (idiopathic) and secondary forms. The primary task of examining a patient with newly diagnosed MGN is to exclude secondary causes of the disease. Primary MGN develops more often in young and middle-aged people. secondary MGN is more common in children. in mgn, it is necessary to test for the A2 phospholipase receptor (PLA2R1) antigen, anti-pla2R1 IgG antibodies and determine the number of cells in the glomerular infiltrate. persons of older age groups in the absence of deposits with anti-pla2R1 antibodies and in the presence of igG2 and iggi deposits need additional examination for the presence of a paraneoplastic process.
Clinical nephrology. 2021;13(3):66-77
pages 66-77 views

Urolithiasis as an extra-articular manifestation of ankylosing spondilitis (literature review)

Nikitina N.M., Kharlamov V.E.

Abstract

The article presents literature data on the incidence and risk factors for the development of urolithiasis in ankylosing spondylitis (ankylosing spondylitis), the features of the course of kidney damage and the underlying disease when they combined. The issues of the relationship between inflammation, calcium metabolism, kidney stone formation and osteoporosis (op) are discussed separately. The directions of further research to predict the development and prevention of kidney stone formation and the development of op in patients with ankylosing spondylitis have been determined. This review expands the doctors' understanding of comorbidity in inflammatory diseases of the joints and spine, in particular in ankylosing spondylitis.
Clinical nephrology. 2021;13(3):78-83
pages 78-83 views

Beyond glycemic control: nephroprotective effects of glucagon-like peptide 1 receptor agonists

Shamkhalova M.S., Sklyanik I.A., Shestakova M.V.

Abstract

Chronic kidney disease in patients with diabetes mellitus (Dm) is the leading cause of end-stage renal failure (ESRD), which determines the high risk of cardiovascular disease and mortality. Advances in diabetes management do not reverse the risks of ESRD, but shift them in line with age and duration of illness. according to large studies of cardiovascular safety, modern hypoglycemic drugs - glucagon-like peptide 1 receptor agonists (GLP-1RAs), effectively control glycemia, components of the metabolic syndrome and significantly reduce the risk of a primary 3-component endpoint (mace) and have an underestimated nephroprotective potential. The renal effects of glp-1RAs are determined by the anti-inflammatory, antiapoptotic, antioxidant properties of this group of drugs.
Clinical nephrology. 2021;13(3):84-91
pages 84-91 views

Discoveries of japanese biochemists that break the traditional understanding of the conversion of threonine and histidine in the human body and the significance of these discoveries in the treatment of uremia

Malinovsky A.V.

Abstract

There were two well-established stereotypes in traditional biochemistry. First: all amino acids, both nonessential and essential, undergo reversible transamination in the human body with α-keto acids, except for lysine and threonine. In uremia, it becomes necessary to replace essential amino acids in a low-protein diet with their α-keto analogs, counting on further transamination of the latter, but the keto analogs of lysine and threonine are not used, since it is believed that these two amino acids are not transaminated. At the end of the last century, Japanese biochemists proved that, unlike lysine, threonine undergoes transamination as well as other amino acids. Second: histidine is not synthesized in the animal body, incl. in the human. But if histidine is an essential amino acid for the vast majority of mammals, then for a healthy adult, histidine is a nonessential amino acid. And only in this century, Japanese biochemists discovered an enzyme that catalyzes the last reaction in the pathway of histidine biosynthesis, and this discovery explains the indispensability/replaceability of histidine for one or another animal species, including humans, as well as a dramatic change in the status of histidine in patients with uremia, which gives good reason for the introduction of histidine into the body of people suffering from renal failure. This article presents these discoveries of Japanese biochemists and discusses the practical application of these discoveries in uremia
Clinical nephrology. 2021;13(3):92-96
pages 92-96 views

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies